Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Glenmark Pharmaceuticals discloses ADH5 inhibitors

Sep. 1, 2016

Constellation Pharmaceuticals describes EZH2 inhibitors

Sep. 1, 2016

Oncocure Biotechnology patents CRM1 inhibitors

Sep. 1, 2016

Sunshine Lake Pharma describes FXR agonists

Aug. 31, 2016

Yissum Research Development reports anticancer agents

Aug. 31, 2016

Ningbo Wenda Pharmaceutical Technology develops EGFR inhibitors

Aug. 31, 2016

Nanjing Gator Meditech and Jilin University patent PI3Kdelta inhibitors

Aug. 31, 2016

Merck Patent discloses NUDT1 inhibitors

Aug. 31, 2016

Chengdu Institute of Biology identifies sparstolonin B derivatives

Aug. 30, 2016

Centaurus BioPharma, Jiangsu Chia Tai Tianqing and Lianyungang Ruzhong patent DPP-IV inhibitors

Aug. 30, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...